Targeting of complement to tumor cells by heteroconjugates composed of antibodies and of the complement component C3b.

Reiter, Y

Targeting of complement to tumor cells by heteroconjugates composed of antibodies and of the complement component C3b. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Apr 1989 - 2771-7 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

0022-1767


Animals
Antibodies, Monoclonal--administration & dosage
Complement C3-C5 Convertases--pharmacology
Complement C3b--administration & dosage
Complement C3b Inactivator Proteins--metabolism
Complement Factor H
Complement Pathway, Alternative
Cytotoxicity, Immunologic
Elapid Venoms--administration & dosage
Humans
Immunotherapy
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Neoplasms--immunology
Tumor Cells, Cultured